Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 30;12(13):4430.
doi: 10.3390/jcm12134430.

Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials

Tri Wisesa Soetisna  1   2 , Ahmad Muslim Hidayat Thamrin  1   3 , Diajeng Permadijana  1 , Andi Nurul Erisya Ramadhani  1 , Sugisman  1   2 , Anwar Santoso  4   5 , Muchtaruddin Mansyur  6
Affiliations
Review

Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials

Tri Wisesa Soetisna et al. J Clin Med. .

Abstract

IMSC transplantation during CABG is considered one of the most promising methods to effectively deliver stem cells and has been widely studied in many trials. But the results of outcomes and safety of this modality still vary widely. We conducted this meta-analysis of randomized controlled trials (RCTs) to evaluate not only the outcome but also the safety of this promising method. A meta-analysis was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A comprehensive literature search was undertaken using the PubMed, Scopus, and Cochrane databases. Articles were thoroughly evaluated and analyzed. Twenty publications about IMSC during CABG were included. Primary outcomes were measured using LVEF, LVESV, LVESVI, LVESD, LVEDV, LVEDVI, LVEDD, WMSI, and 6-MWT. Safety measures were depicted by total deaths, MACE, CRD, CVA, myocardial infarction, ventricular arrhythmia, and cardiac-related readmission. IMSC transplantation during CABG significantly improved LVEF (MD = 3.89%; 95% CI = 1.31% to 6.46%; p = 0.003) and WMSI (MD = 0.28; 95% CI = 0.01-0.56; p = 0.04). Most of the other outcomes showed favorable results for the IMSC group but were not statistically significant. The safety analysis also showed no significant risk difference for IMSC transplantation compared to CABG alone. IMSC during CABG can safely improve cardiac function and tend to improve cardiac volumes and dimensions. The analysis and application of influencing factors that increase patients' responses to IMSC transplantation are important to achieve long-term improvement.

Keywords: coronary artery bypass; intramyocardial; ischemic heart disease; outcome; safety; stem cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines flowchart.
Figure 2
Figure 2
Forest plot of LVEF change (%) difference between ISMC and control group [3,4,8,9,10,18,19,20,21,23,24,25,26,27,28,29,30,31,32].
Figure 3
Figure 3
Forest plot of WMSI change difference between ISMC and control group [3,23,26].
Figure 4
Figure 4
Forest plot of LVESV (mL) change difference between ISMC and control group [3,4,18,19,20,23,24,25,31].
Figure 5
Figure 5
Forest plot of LVESVI change difference between ISMC and control group [8,19,29,32].
Figure 6
Figure 6
Forest plot of LVESD (mm) change difference between ISMC and control group [27,31].
Figure 7
Figure 7
Forest plot of LVEDV (mL) change difference between ISMC and control group [3,4,18,19,20,23,24,25,28,30,31].
Figure 8
Figure 8
Forest plot of LVEDVI change difference between ISMC and control group [8,19,29,32].
Figure 9
Figure 9
Forest plot of LVEDD (mm) change difference between ISMC and control group [27,28,31].
Figure 10
Figure 10
Forest plot of 6-MWT change difference between ISMC and control group [3,19,22,28,32].
Figure 11
Figure 11
Forest plot of total death incidence difference between ISMC and control group [3,4,10,11,18,19,20,21,25,26,27,28,29,30,31,32].
Figure 12
Figure 12
Forest plot of MACE incidence difference between ISMC and control group [3,4,8,9,10,18,19,20,21,23,24,25,26,27,28,29,30,31,32].
Figure 13
Figure 13
Forest plot of myocardial infarct incidence difference between ISMC and control group [3,4,10,11,18,19,20,21,23,25,26,27,28,29,30,31,32].
Figure 14
Figure 14
Forest plot of cerebrovascular incidence difference between ISMC and control group [4,19,20,21,23,25,27,28,29,30,32].
Figure 15
Figure 15
Forest plot of cardiac-related death incidence difference between ISMC and control group [3,4,8,9,10,18,19,21,25,26,27,28,29,30,31,32].
Figure 16
Figure 16
Forest plot of cardiac-related readmission incidence difference between ISMC and control group [4,18,25].
Figure 17
Figure 17
Forest plot of ventricular arrhythmia incidence difference between ISMC and control group [3,4,8,18,19,20,23,24,25,27,28,30,31].
Figure 18
Figure 18
Results of RoB2 assessment. (A) Risk of bias summary: review authors’ judgments about each risk of bias item for each included study using RoB2 for randomized studies. (B) Risk of bias graph: review authors’ judgments about each risk of bias item presented as percentages across all included studies using RoB2 for randomized studies [3,4,8,9,10,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32].
Figure 19
Figure 19
How IMSC transplantation improves patient’s outcomes. Transplanted stem cells can directly differentiate into many kinds of tissues, including cardiomyocytes and endothelial cells [3,9,21,26,27]. This in turn supports myocardial tissue and vasculature repair [3,9,21,26,27]. The transplanted stem cells also release cytokines that exert paracrine effects [3,25,26,27,30,31,32]. Paracrine effects on damaged but viable and hibernating myocardial tissue lead to tissue repair and remodeling attenuation, resulting in LV reverse remodeling [26,30]. This is supported by the paracrine effect on cardiac vessels, which stimulates vasculature repair and angiogenesis, increasing myocardial tissue perfusion and ensuring continuous LV reverse remodeling [3,27,31]. All of these mechanisms together will lead to global LV function improvement, which will result in an overall improvement of patients’ outcomes.
See this image and copyright information in PMC

References

    1. Yerebakan C., Kaminski A., Liebold A., Steinhoff G. Safety of Intramyocardial Stem Cell Therapy for the Ischemic Myocardium: Results of the Rostock Trial after 5-Year Follow-Up. Cell Transplant. 2007;16:935–940. doi: 10.3727/096368907783338280. - DOI - PubMed
    1. Song J., He K., Hou J. Autologous Bone Marrow Stem Cell Transplantation for Patients Undergoing Coronary Artery Bypass Grafting: A Meta-Analysis of 22 Randomized Controlled Trials. J. Cardiothorac. Surg. 2022;17:167. doi: 10.1186/s13019-022-01838-2. - DOI - PMC - PubMed
    1. Soetisna T.W., Sukmawan R., Setianto B., Mansyur M., Murni T.W., Listiyaningsih E., Santoso A. Combined Transepicardial and Transseptal Implantation of Autologous CD133+ Bone Marrow Cells during Bypass Grafting Improves Cardiac Function in Patients with Low Ejection Fraction. J. Card. Surg. 2020;35:740–746. doi: 10.1111/jocs.14454. - DOI - PMC - PubMed
    1. He X., Wang Q., Zhao Y., Zhang H., Wang B., Pan J., Li J., Yu H., Wang L., Dai J., et al. Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease. JAMA Netw. Open. 2020;3:e2016236. doi: 10.1001/jamanetworkopen.2020.16236. - DOI - PMC - PubMed
    1. Li Z., Lin L., Wu H., Yan L., Wang H., Yang H., Li H. Global, Regional, and National Death, and Disability-Adjusted Life-Years (DALYs) for Cardiovascular Disease in 2017 and Trends and Risk Analysis From 1990 to 2017 Using the Global Burden of Disease Study and Implications for Prevention. Front. Public Health. 2021;9:559751. doi: 10.3389/fpubh.2021.559751. - DOI - PMC - PubMed

LinkOut - more resources